Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
8-K
Covenant Breach
confidence 25%
filed 2026-05-26
Item 2.03
This 8-K Item 2.03 discloses the creation of direct financial obligations through the issuance of consolidated obligations (bonds and discount notes) totaling approximately $620 million across four debt instruments with maturities ranging from November 2026 to May 2031. While Item 2.03 is the appropriate disclosure vehicle for new debt obligations, the filing itself does not indicate a covenant breach, acceleration, or triggering event—it is a routine debt issuance disclosure. The low confidence reflects genuine uncertainty about whether this routine debt issuance should be classified as a material event or as "other_material," but covenant_breach is the least appropriate classification given the absence of any breach language.
View raw filing on EDGAR →
8-K
Other material
confidence 65%
filed 2026-05-26
Item 2.03
The filing discloses the Federal Home Loan Bank of Indianapolis becoming the primary obligor on consolidated obligation bonds totaling $100 million across four tranches with maturities ranging from 2030 to 2041. While Item 2.03 is technically about creation of direct financial obligations, this disclosure does not fit cleanly into the covenant_breach category (no breach alleged) and the bonds appear to be routine consolidated obligations issued by the FHLBank system rather than a triggering event of financial distress. The materiality lies in the new debt obligation itself, but the event type taxonomy lacks a dedicated "debt issuance" category, making "other_material" the most appropriate classification for this material but routine debt financing activity.
View raw filing on EDGAR →
8-K
Other material
confidence 72%
filed 2026-05-26
Item 2.03
This 8-K Item 2.03 discloses the creation of direct financial obligations through the issuance of consolidated obligation bonds totaling $500 million ($250M + $250M) by the Federal Home Loan Bank of Dallas. While the filing explicitly states "the Bank has not made a judgment as to the materiality of these consolidated obligation bonds," the issuance of half a billion dollars in debt securities represents a material creation of financial obligations that would affect a reasonable investor's assessment of the registrant's capital structure and leverage. The event does not fit neatly into the more specific taxonomy categories (it is not a covenant breach, going concern, or impairment), making "other_material" the most appropriate classification for this routine but material debt issuance disclosure.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-05-26
Item 5.07
EPAM held its Annual Meeting of Stockholders on April 1, 2026, with stockholders voting on seven matters: election of four Class II directors (Balazs Fejes, Eugene Roman, Jill Smart, Ronald Vargo), approval of charter amendments enabling stockholder-called special meetings, ratification of Deloitte & Touche LLP as independent auditors, an advisory compensation vote, and amendments to the 2025 Long Term Incentive Plan and 2021 Employee Stock Purchase Plan.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 65%
filed 2026-05-26
Item 8.01
The filing announces a special meeting of MHC members scheduled for July 7, 2026, to vote on waiving the MHC's right to receive quarterly dividends up to $1.27 per share over 12 months. While this is technically a notice of a future vote rather than results of a completed vote, the disclosure centers on a shareholder voting event that would materially affect dividend policy and capital allocation. The waiver would allow the Company to retain capital otherwise distributed to the mutual holding company, making this material to investors.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-05-26
Item 5.07
CDW stockholders voted at the Annual Meeting held on May 26, 2026, on five proposals: election of nine directors, advisory vote on named executive officer compensation, ratification of Ernst & Young LLP as auditor, approval of a Certificate of Incorporation amendment permitting written consent, and a stockholder proposal on independent board chair requirements. The filing discloses detailed voting tallies including For, Against, Abstentions, and Broker Non-Votes for each proposal.
View raw filing on EDGAR →
8-K
Other material
confidence 72%
filed 2026-05-26
Item 8.01
Genprex announced publication of a peer-reviewed abstract at the 2026 ASCO Annual Meeting presenting positive clinical data from its Acclaim trials showing that high Trop-2 and low PTEN biomarkers correlate with prolonged PFS in NSCLC patients receiving Reqorsa gene therapy. While this is clinical validation of a lead drug candidate and biomarker discovery that would be material to investors assessing development progress, it does not fit neatly into the standard 8-K taxonomy—it is neither an earnings release, M&A activity, executive change, restatement, nor other specifically enumerated event. The disclosure represents material clinical progress and biomarker validation that would affect a reasonable investor's assessment of the company's pipeline advancement.
View raw filing on EDGAR →
8-K
Exec departure
confidence 95%
filed 2026-05-26
Item 5.02
John Brown, Founder and Executive Chairman of Zion Oil & Gas, passed away on May 22, 2026. This constitutes a departure of a named executive officer due to death. The filing explicitly discloses the death of the company's founder and long-serving Executive Chairman, which is material to investors as it represents a significant leadership transition for the organization.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-05-26
Item 5.07
Smith Micro held its annual stockholder meeting on May 26, 2026, with shareholders voting on eight proposals including director elections, executive compensation approval (say-on-pay), auditor ratification, equity plan amendments, warrant issuance authorizations, and approval of a 1:5 reverse stock split effective June 4, 2026.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-05-26
Item 5.07
This Item 5.07 filing discloses the final results of Patriot National Bancorp's 2026 Annual Meeting of Shareholders held on May 20, 2026, including voting outcomes on three proposals: election of seven directors, authorization for a reverse stock split (1-for-10 to 1-for-20 ratio), and ratification of Baker Tilly US, LLP as independent auditor. The reverse stock split authorization is material to investors as it represents a potential significant capital structure change.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-05-26
Item 2.02
The filing discloses Transcat's financial results for fiscal Q4 and year ended March 28, 2026 via a press release (Exhibit 99.1) and accompanying investor slides (Exhibit 99.2) for an earnings conference call. This is a standard earnings release disclosure under Item 2.02, which is material to investors assessing the company's financial performance.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 72%
filed 2026-05-26
Item 1.01
LiqTech issued $1.1 million in promissory notes to affiliates of Bleichroeder L.P. and Laurence W. Lytton pursuant to a note purchase agreement. The unregistered debt issuance, structured with escalating interest rates (10% rising to 16%) and a short two-month maturity, signals distressed financing typical of small-cap companies under liquidity pressure.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 95%
filed 2026-05-26
Item 5.07
This Item 5.07 disclosure reports the results of the Company's Annual Meeting of Stockholders held on May 20, 2026, including the election of director Lydia I. Beebe and ratification of KPMG LLP as independent auditor. The filing presents voting tallies (For, Against, Withhold, Abstain, Broker Non-Votes) for each proposal, which is the standard format for shareholder vote results disclosures required under Item 5.07.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 85%
filed 2026-05-26
Item 3.02
Transocean completed an unregistered sale of equity securities, with charter amendments approved by shareholders to authorize issuance of up to 240.8 million shares and 100 million treasury shares, reflecting a material dilutive capital structure change.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-05-26
Item 5.07
Transocean held its Annual General Meeting on May 26, 2026, with shareholders voting on 11 proposals including financial statement approval, director elections (Jeremy D. Thigpen as Chair), compensation committee elections, auditor ratification, and executive compensation matters.
View raw filing on EDGAR →
8-K
M&A activity
confidence 75%
filed 2026-05-26
Item 1.01
Cartesian Therapeutics entered into a material Loan and Security Agreement on May 22, 2026, providing up to $150 million in senior secured term loans with $50 million funded at closing. The facility includes conversion rights, security interests in substantially all assets, and restrictive covenants, representing a material capital structure change with significant financial implications.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 92%
filed 2026-05-26
Item 3.02
Cartesian Therapeutics disclosed an unregistered sale of equity securities in the form of conversion shares underlying the Term Loans, to be issued in reliance on Section 4(a)(2) and Rule 506(b) of Regulation D. This convertible debt structure will materially affect shareholder equity and voting power.
View raw filing on EDGAR →
8-K
Exec departure
confidence 95%
filed 2026-05-26
Item 5.02
Milos Miljkovic, M.D., Chief Medical Officer, delivered notice of resignation on May 22, 2026, with employment ceasing May 31, 2026. The disclosure includes severance terms negotiated in connection with the departure.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-05-26
Item 5.02
Dropbox appointed Ashraf Alkarmi as Co-Chief Executive Officer and Board member effective May 26, 2026, with Andrew Houston transitioning to Executive Chairman. Michael Torres was also appointed as Chief Product Officer as part of the leadership restructuring.
View raw filing on EDGAR →
8-K
Other material
confidence 65%
filed 2026-05-26
Item 7.01
Dropbox provided updated guidance for Q2 2026 and FY 2026 financial results, indicating performance expected to be in-line with or above previously provided guidance ranges, along with a blog post addressing matters related to the leadership transitions.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-05-26
Item 5.07
This Item 5.07 discloses the results of Dropbox's 2026 Annual Meeting of Stockholders held on May 21, 2026, including voting outcomes on four proposals: election of seven directors, ratification of Ernst & Young LLP as auditors, advisory approval of named executive officer compensation, and approval of amended articles of incorporation to waive jury trials. The filing provides detailed vote tallies for each proposal, all of which passed. This is a classic shareholder vote results disclosure material to investors assessing corporate governance and board composition.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-05-26
Item 5.07
Northwest Bancshares held its Annual Meeting of Shareholders on May 20, 2026, with voting results on five proposals: election of three directors (Kranich, Williams, Torchio), ratification of KPMG LLP as independent auditor, advisory approval of executive compensation, and approval of the 2026 Equity Incentive Plan and Discounted Stock Purchase Plan. All proposals passed with substantial majorities.
View raw filing on EDGAR →
8-K
Other material
confidence 75%
filed 2026-05-26
Item 7.01
The Company announced filing an application to seek listing on the Nasdaq Capital Market. While this is a significant corporate development that would materially affect investor assessment of the registrant's status and market access, it does not fit neatly into the delisting_risk category (which addresses delisting notices or failures to maintain listing standards). The announcement of a listing application is a material event but falls outside the more specific taxonomy categories, making other_material the most appropriate classification.
View raw filing on EDGAR →
8-K
Exec departure
confidence 95%
filed 2026-05-26
Item 5.02
Jiri Ponrt, Chief Operating Officer of Groupon, notified the Company on May 21, 2026 of his decision to resign from employment, effective July 10, 2026. The departure is voluntary and unrelated to any disagreement with the Company.
View raw filing on EDGAR →
8-K
Other material
confidence 75%
filed 2026-05-26
Item 2.05
The Board approved a restructuring plan involving up to 400 workforce reductions globally, with estimated pre-tax charges of $7–$13 million and expected annualized cost savings of $20–$25 million. The restructuring is tied to the company's AI-native strategy and includes additional material cost-reduction actions under evaluation, with upward revision of Full Year Adjusted EBITDA guidance.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-05-26
The filing discloses the appointment of Andrew Penn as a member and Chair of the Board of Directors of SharonAI Holdings Inc., effective May 21, 2026. The disclosure includes Penn's extensive background as former CEO of Telstra Corporation Limited and AXA Asia Pacific Holdings, along with his current roles and honors. The appointment is accompanied by a Director Appointment Letter detailing equity compensation (40,000 initial RSUs plus 6,944 annual RSUs) and $165,000 annual cash compensation. This is a material executive appointment that would affect a reasonable investor's assessment of the company's governance and leadership.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 92%
filed 2026-05-26
The filing discloses results of a shareholder vote at the May 21, 2026 Extraordinary General Meeting on three proposals: (1) authorization for a 1-for-10 share consolidation, (2) adoption of amended articles of association, and (3) approval of the 2026 Equity Incentive Plan. Item 5.07 explicitly presents vote tallies (For, Against, Abstentions) for each proposal, which is the core disclosure requirement for shareholder vote results. The share consolidation and equity plan approval are material corporate actions affecting shareholders.
View raw filing on EDGAR →
8-K
Other material
confidence 65%
filed 2026-05-26
The filing discloses that Worksport Ltd. secured a U.S. patent for an "industry-first" Zerofrost Heat Pump through its subsidiary Terravis Energy. While this represents a material intellectual property achievement that could affect investor assessment of the company's competitive position and product pipeline, it does not fit neatly into the standard 8-K event taxonomy (not earnings, M&A, executive changes, impairment, litigation, or other defined categories). The patent grant is disclosed via Item 7.01 (Regulation FD Disclosure) rather than a dedicated Item, suggesting the company classified it as a material event outside standard categories.
View raw filing on EDGAR →
8-K
Other material
confidence 55%
filed 2026-05-26
The filing discloses a press release regarding "novel direct-acting antivirals" under Item 7.01 (Regulation FD Disclosure). Without access to the actual press release content (Exhibit 99.1), the materiality and specific event type cannot be definitively determined. The disclosure could relate to clinical trial results, product development milestones, or other significant pharmaceutical developments. Given the uncertainty about the substantive content and the lack of a more specific event category that clearly fits, "other_material" is the most appropriate classification, with moderate confidence reflecting the information gap.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 95%
filed 2026-05-26
The filing discloses Item 5.07 results from the Annual Meeting of Shareholders held on May 20, 2026, including final vote tabulations for the election of two Class B Directors (Yvonne L. Murphy and William J. Nance) and ratification of Whitley Penn LLP as independent auditor. These are standard shareholder voting outcomes that are material to investors' understanding of corporate governance and auditor selection.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 95%
filed 2026-05-26
The filing discloses Item 5.07 results from Portsmouth Square's Fiscal 2025 Annual Meeting of Shareholders held on May 20, 2026, including final vote tabulations for the election of five directors (John V. Winfield, William J. Nance, Yvonne L. Murphy, Steve Grunwald, and Andrew J. Kaplan) and ratification of Whitley Penn LLP as independent auditor. This is a routine but material shareholder vote disclosure required by Item 5.07.
View raw filing on EDGAR →
8-K
Other material
confidence 75%
filed 2026-05-26
The filing discloses amendments to the Certificate of Incorporation and Bylaws that materially restrict stockholder rights. Specifically, Section C of Article VII eliminates stockholders' ability to take action by written consent and requires all stockholder actions to occur at duly called meetings. This is a material governance change that affects the rights and protections of security holders, though it does not fit neatly into the standard event taxonomy categories.
View raw filing on EDGAR →
8-K
Delisting risk
confidence 75%
filed 2026-05-26
The filing discloses two material events: (1) a private placement of 500,000 shares for $500,000 (Item 1.01, 3.02), and (2) a Nasdaq deficiency letter on May 26, 2026 notifying the Company it failed to maintain the minimum $2.5 million stockholders' equity requirement under Listing Rule 5550(b)(1) (Item 3.01). While the private placement itself is a dilutive issuance, the delisting risk is the more material and time-sensitive disclosure—the Company has 45 days to submit a compliance plan or face potential delisting. The deficiency letter represents a direct threat to continued listing and would materially affect investor assessment of the registrant's viability.
View raw filing on EDGAR →
8-K
Other material
confidence 72%
filed 2026-05-26
Lipocine disclosed presentation of Phase 3 clinical trial results for LPCN 1154 (oral brexanolone) for postpartum depression treatment at the ASCP Annual Meeting on May 26, 2026. While this represents material clinical progress for a biopharmaceutical company's lead candidate, it does not fit neatly into the standard taxonomy categories—it is neither an earnings release, M&A activity, executive change, nor a negative event like impairment or litigation. The disclosure of positive Phase 3 data would materially affect investor assessment of the company's pipeline prospects and regulatory pathway.
View raw filing on EDGAR →
8-K
Other material
confidence 75%
filed 2026-05-26
The filing discloses a court-appointed receivership over the company (appointed September 18, 2024) and the filing of a Seventh Interim Report by the Receiver describing ongoing receivership activities, including resignation of the independent auditor, audit status issues for fiscal years 2023-2024, misappropriated funds, and pending litigation. While receivership is a terminal financial event, it does not fit neatly into the bankruptcy_filing category (which typically refers to formal bankruptcy proceedings under Chapter 7 or 11) nor any other specific taxonomy event. This is a material disclosure affecting investor assessment of the registrant's viability and control.
View raw filing on EDGAR →
8-K
Delisting risk
confidence 98%
filed 2026-05-26
Item 3.01 discloses that Vestand Inc. received a Staff Delisting Determination from Nasdaq on May 19, 2026, initiating a process that could result in delisting of the Company's Class A Common Stock due to failure to file delinquent quarterly and annual reports (September 2025 10-Q, 2025 10-K, and March 2026 10-Q). The filing explicitly states that if the Company's requests for stay and extension are not granted, "the Company's shares of Class A Common Stock will be delisted from the Nasdaq stock exchange." This is a clear delisting risk disclosure under Item 3.01.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-05-26
Item 5.02
Anthony Catalano was appointed as Chief Operating Officer on May 14, 2026, with a detailed employment agreement specifying $400,000 base salary, $50,000 sign-on bonus, equity awards of 0.30% of outstanding shares, and severance provisions. While the section also mentions Michael Miller's transition to Chief Technology and Products Officer, the principal disclosed action centers on Catalano's appointment to a C-suite role with material compensation and equity arrangements.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-05-26
Item 5.07
This is a clear Item 5.07 disclosure of shareholder vote results from Pinterest's May 21, 2026 annual meeting. The filing reports voting outcomes on four proposals: election of four Class I directors (Chip Bergh, Gokul Rajaram, Emily Reuter, Marc Steinberg), advisory approval of named executive officer compensation, frequency of future advisory compensation votes (determined to be annual), and ratification of Ernst & Young LLP as independent auditor. All proposals passed with substantial majorities, and the specific vote tallies for each matter are provided.
View raw filing on EDGAR →
8-K
Restatement
confidence 95%
filed 2026-05-26
Item 4.02
The filing explicitly discloses non-reliance on the Annual Report on Form 10-K for fiscal year 2025 due to identified errors in bank and credit card statement accounting. The Company is preparing a Form 10-K/A amendment to correct material misstatements including an $83,422 understatement of expenses, $121,122 understatement of liabilities, and $40,000 overstatement of paid-in capital. This is a classic financial restatement under Item 4.02, material to investors assessing the registrant's financial position and internal controls.
View raw filing on EDGAR →
8-K
M&A activity
confidence 92%
filed 2026-05-26
Item 2.01
ESG Inc. completed a split-off and share exchange transaction on May 26, 2026, transferring 100% of ESG China Limited (a subsidiary) in exchange for the redemption and cancellation of 10,432,800 shares of common stock. The transaction materially alters the company's asset base, operational scope, and capital structure by separating the China business and retiring a significant portion of outstanding shares.
View raw filing on EDGAR →
8-K
Other material
confidence 75%
filed 2026-05-26
Item 8.01
This Item 8.01 discloses the closing of a commercial mortgage-backed securitization (CMBS) transaction on May 26, 2026, involving the issuance of approximately $729.9 million in certificates by Benchmark 2026-V22 Mortgage Trust. While the filing describes the transaction structure, underwriters, and credit risk retention arrangements under Regulation RR, it does not fit neatly into the standard 8-K event taxonomy. The disclosure is material to investors as it documents a significant securitization closing with multiple certificate classes and substantial principal amounts, but the event is best classified as "other_material" rather than a more specific category like ma_activity, since it represents the closing of a securitization vehicle rather than a traditional acquisition or disposition by the registrant itself.
View raw filing on EDGAR →
8-K
M&A activity
confidence 75%
filed 2026-05-26
Item 8.01
The filing discloses entry into underwriting and certificate purchase agreements on May 21, 2026, for the sale of approximately $832.6 million in commercial mortgage pass-through certificates (publicly and privately offered). While structured as a securitization rather than a traditional M&A transaction, this represents a material capital-raising and asset acquisition activity—the Registrant is acquiring 27 commercial and multifamily mortgage loans from Wells Fargo Bank, Bank of America, Morgan Stanley, and JPMorgan Chase, funded by the certificate issuances. The transaction is scheduled to close June 11, 2026, and involves multiple underwriters and servicers, making it a material financing and asset acquisition event.
View raw filing on EDGAR →
8-K
Other material
confidence 75%
filed 2026-05-26
Item 8.01
The Board approved a $200 million share repurchase program, which is a material capital allocation decision affecting shareholder value and the company's financial position. While share repurchases are common corporate actions, a $200 million program represents a significant commitment of available cash and would affect a reasonable investor's assessment of capital strategy and financial flexibility. This does not fit neatly into the more specific event categories (it is not an earnings release, M&A activity, executive change, or financial restatement), making "other_material" the appropriate classification.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-05-26
Item 2.02
The Cato Corporation issued a press release on May 21, 2026 disclosing financial results for the first quarter ending May 2, 2026.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-05-26
Item 5.07
The company held its Annual Meeting on May 21, 2026 and disclosed voting results for three proposals: election of three directors, advisory approval of executive compensation, and ratification of PricewaterhouseCoopers LLP as independent auditor.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-05-26
Item 3.02
The filing discloses an unregistered sale of 7,000 shares of Series C Convertible Preferred Stock for $6,990,000 completed on May 20, 2026, under Section 4(a)(2) and Regulation D Rule 506(b). The preferred shares are convertible into common stock, making this a dilutive equity issuance. The substantial purchase price and convertible nature of the securities indicate material capital raising activity typical of Item 3.02 disclosures.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 92%
filed 2026-05-26
Item 3.02 discloses an unregistered sale of 11,364 common shares of beneficial interest for approximately $0.3 million at $23.32 per share, exempt under Section 4(a)(2) and Regulation D Rule 506. This is a private placement of equity securities that dilutes existing shareholders and is material to investors assessing the fund's capital structure and share count.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-05-26
Item 2.02
The filing discloses CSW Industrials' financial results for the fiscal fourth quarter ended March 31, 2026, via a press release furnished as Exhibit 99.1. This is a standard quarterly earnings release under Item 2.02, which is material to investors as it provides the company's periodic financial performance and results of operations.
View raw filing on EDGAR →
8-K
M&A activity
confidence 95%
filed 2026-05-26
Item 1.01
Octave Intelligence completed a spin-off distribution from Hexagon AB on May 22, 2026, whereby Hexagon shareholders received Octave shares in a 1-for-10 ratio. The transaction involved entry into multiple material definitive agreements (Distribution Agreement, Tax Disaffiliation Agreement, Employee Matters Agreement, Master Transition Services Agreement, and Registration Rights Agreement) and constitutes a fundamental change of control and separation event.
View raw filing on EDGAR →
8-K
M&A activity
confidence 75%
filed 2026-05-26
Item 2.03
Octave Intelligence entered into a significant credit facility ($500M revolving + $350M USD + €150M term loans) on April 27, 2026, with full drawdown of the Term Loan Facility and partial drawdown of the Revolving Credit Facility to fund a $625 million cash payment to Hexagon in connection with the spin-off distribution.
View raw filing on EDGAR →